货号:GS40651
Setrusumab is a fully human monoclonal antibody targeting sclerostin (SOST), a glycoprotein secreted by osteocytes that inhibits bone formation by blocking Wnt/β-catenin signaling. By neutralizing sclerostin, it promotes osteoblast activity and new bone formation. It is being developed for the treatment of osteoporosis and osteogenesis imperfecta, aiming to increase bone mineral density and reduce fracture risk.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯